Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Operating Expenses: 2014-2024

Historic Operating Expenses for Collegium Pharmaceutical (COLL) over the last 11 years, with Dec 2024 value amounting to $207.4 million.

  • Collegium Pharmaceutical's Operating Expenses rose 8.28% to $67.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $276.2 million, marking a year-over-year increase of 53.25%. This contributed to the annual value of $207.4 million for FY2024, which is 30.30% up from last year.
  • According to the latest figures from FY2024, Collegium Pharmaceutical's Operating Expenses is $207.4 million, which was up 30.30% from $159.2 million recorded in FY2023.
  • In the past 5 years, Collegium Pharmaceutical's Operating Expenses ranged from a high of $207.4 million in FY2024 and a low of $123.6 million during FY2020.
  • Its 3-year average for Operating Expenses is $180.9 million, with a median of $176.2 million in 2022.
  • Per our database at Business Quant, Collegium Pharmaceutical's Operating Expenses skyrocketed by 32.47% in 2022 and then decreased by 9.63% in 2023.
  • Yearly analysis of 5 years shows Collegium Pharmaceutical's Operating Expenses stood at $123.6 million in 2020, then grew by 7.59% to $133.0 million in 2021, then soared by 32.47% to $176.2 million in 2022, then decreased by 9.63% to $159.2 million in 2023, then spiked by 30.30% to $207.4 million in 2024.